Replies to post #13901 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[tmf1955]

Please be more specific as to problems with the SEC. As far as my experience with Agora, I have found them to be very informative, and have no complaints. The information provided, as with any newsletter, requires our own due diligence.